Uromems
Growth/LateUromems raised €52M in a Growth/Late round in May 2026. The company is based in Grenoble, France. Investors in the round: Ajax Health Fund I. Data as of Nov 2026.
Amount raised
€52M
€51,599,587
Native amount
60,000,000 USD
Stage
Growth/Late
growth equity
Investors
1
Provenance & confidence
High confidenceAmount
60,000,000 USD
ECB-at-date → €52M · rate 1.1628 on 2026-05-15
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.